Robert Hadfield - Net Worth and Insider Trading
Robert Hadfield Net Worth
The estimated net worth of Robert Hadfield is at least $2,436 dollars as of 2024-09-20. Robert Hadfield is the General Counsel and Secretary of Alaunos Therapeutics Inc and owns about 889 shares of Alaunos Therapeutics Inc (TCRT) stock worth over $2,436. Details can be seen in Robert Hadfield's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Robert Hadfield has not made any transactions after 2021-01-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Robert Hadfield
Robert Hadfield Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Robert Hadfield owns 2 companies in total, including Alaunos Therapeutics Inc (TCRT) , and Salarius Pharmaceuticals Inc (SLRX) .
Click here to see the complete history of Robert Hadfield’s form 4 insider trades.
Insider Ownership Summary of Robert Hadfield
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TCRT | Alaunos Therapeutics Inc | 2021-01-08 | General Counsel and Secretary |
| SLRX | Salarius Pharmaceuticals Inc | 2015-01-28 | General Counsel & Secretary |
Robert Hadfield Latest Holdings Summary
Robert Hadfield currently owns a total of 1 stock. Robert Hadfield owns 889 shares of Alaunos Therapeutics Inc (TCRT) as of January 8, 2021, with a value of $2,436.
Latest Holdings of Robert Hadfield
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TCRT | Alaunos Therapeutics Inc | 2021-01-08 | 889 | 2.74 | 2,436 |
Holding Weightings of Robert Hadfield
Robert Hadfield Form 4 Trading Tracker
According to the SEC Form 4 filings, Robert Hadfield has made a total of 2 transactions in Alaunos Therapeutics Inc (TCRT) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Alaunos Therapeutics Inc is the sale of 177 shares on January 8, 2021, which brought Robert Hadfield around $82,680.
Insider Trading History of Robert Hadfield
- 1
Robert Hadfield Trading Performance
Robert Hadfield Ownership Network
Robert Hadfield Owned Company Details
What does Alaunos Therapeutics Inc do?
Who are the key executives at Alaunos Therapeutics Inc?
Robert Hadfield is the General Counsel and Secretary of Alaunos Therapeutics Inc. Other key executives at Alaunos Therapeutics Inc include director & Chief Executive Officer Boyle Kevin S. Sr. , VP & Finance Michael Wong , and See Remarks Abhishek K Srivastava .
Alaunos Therapeutics Inc (TCRT) Insider Trades Summary
Over the past 18 months, Robert Hadfield made no insider transaction in Alaunos Therapeutics Inc (TCRT). Other recent insider transactions involving Alaunos Therapeutics Inc (TCRT) include a net sale of 68,014 shares made by Boyle Kevin S. Sr. ,
In summary, during the past 3 months, insiders sold 0 shares of Alaunos Therapeutics Inc (TCRT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 453 shares of Alaunos Therapeutics Inc (TCRT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 453 shares.
Alaunos Therapeutics Inc (TCRT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Alaunos Therapeutics Inc Insider Transactions
Robert Hadfield Mailing Address
Above is the net worth, insider trading, and ownership report for Robert Hadfield. You might contact Robert Hadfield via mailing address: C/o Flex Pharma, Inc., 800 Boylston Street, 24th Floor, Boston Ma 02199.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
